Metraipolis › archive › dc_ee42d114ee15
Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI) — Europe PMC PMID:41467108
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41467108
- DOI
- 10.1016/j.ctro.2025.101093
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T21:13:49.056Z
- SHA-256 of the archived text
731c9b8ba5f932e2feaaeff174dc1639e2cecdddafa16061c30c9cde5b8d95e7- Stable URL of this page
https://metraipolis.com/documento/dc_ee42d114ee15
How to cite
Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI) — Europe PMC PMID:41467108 — Europe PMC (en), https://europepmc.org/article/MED/41467108 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ee42d114ee15 (Metraipolis archive dc_ee42d114ee15, sha256 731c9b8ba5f932e2feaaeff174dc1639e2cecdddafa16061c30c9cde5b8d95e7)
BibTeX
@misc{dcee42d114ee15,
title = {Benefit of prophylactic pelvic irradiation in intermediate-risk prostate cancer: A multicenter retrospective study (iPPAPI) — Europe PMC PMID:41467108},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41467108},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ee42d114ee15; sha256 731c9b8ba5f932e2feaaeff174dc1639e2cecdddafa16061c30c9cde5b8d95e7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41467108. Agents can read the archived copy with the MCP tool read_document.